Search Results - "Aasebø, Kristine"

Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II–III colon cancer by Hestetun, Kjersti Elvestad, Aasebø, Kristine, Rosenlund, Nina Benedikte, Müller, Yvonne, Dahl, Olav, Myklebust, Mette Pernille

“…Mismatch repair (MMR) deficiency is an indicator of good prognosis in localized colon cancer but also associated with lack of expression of caudal-type…”
Get full text

High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort by Sorbye, Halfdan, Dragomir, Anca, Sundström, Magnus, Pfeiffer, Per, Thunberg, Ulf, Bergfors, Monica, Aasebø, Kristine, Eide, Geir Egil, Ponten, Fredrik, Qvortrup, Camilla, Glimelius, Bengt

“…RAS and BRAF mutations impact treatment and prognosis of metastatic colorectal cancer patients (mCRC), but the knowledge is based on trial patients usually not…”
Get full text

Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients by Aasebø, Kristine, Bruun, Jarle, Bergsland, Christian H., Nunes, Luís, Eide, Geir Egil, Pfeiffer, Per, Dahl, Olav, Glimelius, Bengt, Lothe, Ragnhild A., Sorbye, Halfdan

“…Background Tumour-infiltrating CD3, CD8 lymphocytes and CD68 macrophages are associated with favourable prognosis in localised colorectal cancer, but the…”
Get full text

CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup by Aasebø, Kristine, Dragomir, Anca, Sundström, Magnus, Mezheyeuski, Artur, Edqvist, Per-Henrik, Eide, Geir Egil, Ponten, Fredrik, Pfeiffer, Per, Glimelius, Bengt, Sorbye, Halfdan

“…Survival of metastatic colorectal cancer (mCRC) patients has improved, but mainly for trial patients. New predictive and prognostic biomarkers validated in the…”
Get full text

Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis by Nunes, Luís, Aasebø, Kristine, Mathot, Lucy, Ljungström, Viktor, Edqvist, Per-Henrik, Sundström, Magnus, Dragomir, Anca, Pfeiffer, Per, Ameur, Adam, Ponten, Fredrik, Mezheyeuski, Artur, Sorbye, Halfdan, Sjöblom, Tobias, Glimelius, Bengt

“…We have reported that V600E mutations and microsatellite instability-high (MSI-H) are more prevalent in a population-based cohort of metastatic colorectal…”
Get more information

Consequences of a high incidence of microsatellite instability and BRAF‐mutated tumors: A population‐based cohort of metastatic colorectal cancer patients by Aasebø, Kristine Ø., Dragomir, Anca, Sundström, Magnus, Mezheyeuski, Artur, Edqvist, Per‐Henrik, Eide, Geir Egil, Ponten, Fredrik, Pfeiffer, Per, Glimelius, Bengt, Sorbye, Halfdan

“…Background Immunotherapy for patients with microsatellite‐instable (MSI‐H) tumors or BRAF‐inhibitors combination treatment for BRAF‐mutated (mutBRAF) tumors in…”
Get full text

Abstract 2610: Consequences of a high incidence of microsatellite instability (non-Lynch) and BRAF mutated tumors in a population based cohort of metastatic colorectal cancer by Aasebø, Kristine, Dragomir, Anca, Sundström, Magnus, Pfeiffer, Per, Edqvist, Per-Henrik, Eide, Geir, Ponten, Fredrik, Qvortrup, Camilla, Glimelius, Bengt, Sørbye, Halfdan

“…Abstract Background: Clinical trials in metastatic colorectal cancer (mCRC) have shown few patients with microsatellite instable high (MSI-H) tumors and BRAF…”
Get full text